Literature DB >> 1421741

RSD score: criteria for the diagnosis of reflex sympathetic dystrophy and causalgia.

J J Gibbons1, P R Wilson.   

Abstract

No standardized criteria for the diagnosis of reflex sympathetic dystrophy (RSD) are in common use. An RSD score scoring system of diagnostic criteria is proposed. Diagnosis of reflex sympathetic dystrophy by RSD score correlated well with clinical diagnosis in a group of 25 patients who had treatment for chronic upper extremity pain. Standardization of diagnostic criteria with the RSD score should enhance comparison of the outcomes of studies concerning the treatment of RSD.

Entities:  

Mesh：

Year:  1992        PMID： 1421741

Source DB:  PubMed          Journal:  Clin J Pain        ISSN： 0749-8047            Impact factor:   3.442


  4 in total

1.  Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition.

Authors:  R Norman Harden; Candida S McCabe; Andreas Goebel; Michael Massey; Tolga Suvar; Sharon Grieve; Stephen Bruehl
Journal:  Pain Med       Date:  2022-06-10       Impact factor: 3.637

2.  Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome.

Authors:  R Norman Harden; Stephen Bruehl; Roberto S G M Perez; Frank Birklein; Johan Marinus; Christian Maihofner; Timothy Lubenow; Asokumar Buvanendran; Sean Mackey; Joseph Graciosa; Mila Mogilevski; Christopher Ramsden; Melissa Chont; Jean-Jacques Vatine
Journal:  Pain       Date:  2010-05-20       Impact factor: 6.961

Review 3.  Highlighting the Role of Biomarkers of Inflammation in the Diagnosis and Management of Complex Regional Pain Syndrome.

Authors:  Krishna D Bharwani; Willem A Dik; Maaike Dirckx; Frank J P M Huygen
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

Review 4.  From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome.

Authors:  Thomas J P Mangnus; Krishna D Bharwani; Maaike Dirckx; Frank J P M Huygen
Journal:  Drugs       Date:  2022-03-05       Impact factor: 11.431
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.